Antiplatelet prescribing has become ever more confusing with aspirin hailed for preventing cancer, clopidogrel’s patent expiring and several new drugs launched – this interactive module uses GP case studies to bring you right up to date with the evidence and guidelines.
To improve your understanding of:
- The role of aspirin in primary and secondary prevention of cardiovascular disease
- The potential benefits of aspirin in reducing the risk of cancer
- The options for antiplatelet therapy in the secondary prevention of cardiovascular disease
- Where newer drugs such as ticagrelor and prasugrel might fit in
In this interactive module, you will learn as you work through real-life primary care patient scenarios. You will be assessed before starting the module and again at the end, to gauge how your knowledge has improved.
You don’t have to complete the whole module in one sitting. You can break off at any point mid-module and pick up again where you left off by pressing the Resume Module button alongside the module title in your Pulse Learning CPD log.